Loading...

Monte Buchsbaum

TitleEmeritus Professor
InstitutionUniversity of California San Diego
DepartmentPsychiatry
Address9500 Gilman Drive #0822
La Jolla CA 92093
Phone858-246-1163
vCardDownload vCard

    Collapse Overview 
    Collapse Overview

    Biography

    Monte S. Buchsbaum, MD, has joined the faculty of the University of California, San Diego as Distinguished Professor of Psychiatry and Radiology. He heads the new NeuroPET Center and leads an effort in developing an expanded research effort with positron emission tomography. Located in Sorrento Valley about 2 miles north of the main campus at 11388 Sorrento Valley Road and close to the UCSD MRI and MEG facilities, the Center will be capable of metabolic studies with fluorodeoxyglucose, and initial radioligand studies of the serotonin transporter with DASB, brain amyloid with PIB, and the dopamine receptor with fallypride for cortical and thalamic receptors and raclopride for striatal receptors. An expanded on-site radiochemistry facility will developed a repertoire of molecular probes for imaging. Coordination with MRI for anatomical analysis of images will be a central feature.

    Dr. Buchsbaum was previously Director of the Neuroscience PET Laboratory at Mt. Sinai Hospital in New York City, has been a pioneer in brain-mapping studies of schizophrenia, both with topographic EEG and PET explorations of antipsychotic-drug effects and the role of the prefrontal cortex and attention in this complex disorder. Since 1980, the primary focus of Dr. Buchsbaum's research has been brain imaging, combining positron emission tomography, computerized EEG and evoked potential brain mapping, and later magnetic resonance imaging and diffusion tensor imaging. While in the Intramural Research Program at the National Institute of Mental Health, Dr. Buchsbaum published some of the first PET studies in psychiatry. In 1982, Dr. Buchsbaum left the NIMH to head the Brain Imaging Center at the University of California, Irvine (UCI) and carried out studies on the prefrontal cortex in schizophrenia using FDG-PET and EEG. In 1992, Dr. Buchsbaum moved to New York to head the Neuroscience PET laboratory, focusing on pharmacological response and PET-FDG. In 1998 he published the first report on diffusion tensor imaging in schizophrenia, extending his work on potential deficits in the prefrontal cortex in schizophrenia. He is Editor of Psychiatry Research and Co-Editor of Psychiatry Research: Neuroimaging. He has published over 500 research reports in scientific journals, the majority on positron emission tomography. He is included in the Institute of Scientific Information data base as one of the most highly-cited scientists (ISIHighlyCited.com).


    Collapse Research 
    Collapse Research Activities and Funding
    PET Imaging of OFC and Amygdala in Panic Disorder
    NIH/NIMH R01MH071827Apr 15, 2006 - Mar 31, 2009
    Role: Principal Investigator
    M-CPP PET Scanning of Alcoholism:Effects of Sertraline
    NIH/NIAAA R01AA013164Sep 26, 2002 - Jun 30, 2008
    Role: Principal Investigator
    Anatomy and Function of the Thalamus in Schizophrenia
    NIH/NIMH R01MH060023Aug 1, 1999 - Mar 31, 2009
    Role: Principal Investigator
    NORMAL METABOLISM AND ANATOMY OF BASAL FOREBRAIN IN MAN
    NIH/NIMH R01MH056489May 1, 1998 - Feb 28, 2002
    Role: Principal Investigator
    SERTRALINE AND NALTREXONE FOR ALCOHOL DEPENDENTS
    NIH/NIAAA R01AA011222Sep 1, 1997 - Aug 31, 2003
    Role: Principal Investigator
    ASIP-UNIVERSITY OF CALIFORNIA-IRVINE
    NIH/NIMH S15MH045868Sep 1, 1989 - Aug 31, 1990
    Role: Principal Investigator
    PET IMAGING OF PERFORMANCE TASK IN SCHIZOPHRENIA
    NIH/NIMH R01MH043229Aug 1, 1988 - Jan 31, 1992
    Role: Principal Investigator
    PET STUDIES OF SLEEP IN AFFECTIVE DISORDERS
    NIH/NIMH R01MH041282Mar 15, 1987 - Apr 30, 1992
    Role: Principal Investigator
    PET STUDIES OF ATTENTION IN SCHIZOPHRENIA
    NIH/NIMH R01MH040071Mar 1, 1986 - Jun 30, 1997
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mitelman SA, Bralet MC, Mehmet Haznedar M, Hollander E, Shihabuddin L, Hazlett EA, Buchsbaum M. Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging Behav. 2018 Apr; 12(2):532-546. PMID: 28425060.
      View in: PubMed
    2. Mitelman SA, Bralet MC, Haznedar MM, Hollander E, Shihabuddin L, Hazlett EA, Buchsbaum M. Diametrical relationship between gray and white matter volumes in autism spectrum disorder and schizophrenia. Brain Imaging Behav. 2017 Dec; 11(6):1823-1835. PMID: 27882449.
      View in: PubMed
    3. Mitelman SA, Buchsbaum M, Young DS, Haznedar MM, Hollander E, Shihabuddin L, Hazlett EA, Bralet MC. Increased white matter metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging Behav. 2017 Nov 22. PMID: 29168086.
      View in: PubMed
    4. Garito T, Roubenoff R, Hompesch M, Morrow L, Gomez K, Rooks D, Meyers C, Buchsbaum M, Neelakantham S, Swan T, Filosa LA, Laurent D, Petricoul O, Zakaria M. Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals. Diabetes Obes Metab. 2018 Jan; 20(1):94-102. PMID: 28643356.
      View in: PubMed
    5. Bomyea J, Matthews SC, Buchsbaum M, Spadoni AD, Strigo IA, Simmons AN. Neural differences underlying face processing in veterans with TBI and co-occurring TBI and PTSD. J Affect Disord. 2017 12 01; 223:130-138. PMID: 28753471.
      View in: PubMed
    6. Vyas NS, Buchsbaum M, Lehrer DS, Merrill BM, DeCastro A, Doninger NA, Christian BT, Mukherjee J. D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia. Schizophr Res. 2018 Feb; 192:442-456. PMID: 28576546.
      View in: PubMed
    7. Bralet MC, Buchsbaum M, DeCastro A, Hazlett EA, Mehmet Haznedar M, Shihabuddin L, Mitelman SA. Erratum to: FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2016 Jun; 266(4):379. PMID: 26620489.
      View in: PubMed
    8. Kosheleva E, Spadoni AD, Strigo IA, Buchsbaum M, Simmons AN. Faking bad: The neural correlates of feigning memory impairment. Neuropsychology. 2016 Mar; 30(3):377-84. PMID: 26765340.
      View in: PubMed
    9. Buchsbaum M, Simmons AN, DeCastro A, Farid N, Matthews SC. Clusters of Low (18)F-Fluorodeoxyglucose Uptake Voxels in Combat Veterans with Traumatic Brain Injury and Post-Traumatic Stress Disorder. J Neurotrauma. 2015 Nov 15; 32(22):1736-50. PMID: 25915799.
      View in: PubMed
    10. Bralet MC, Buchsbaum M, DeCastro A, Shihabuddin L, Mitelman SA. FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2016 Sep; 266(6):481-94. PMID: 26370275.
      View in: PubMed
    11. Spadoni AD, Kosheleva E, Buchsbaum M, Simmons AN. Neural correlates of malingering in mild traumatic brain injury: A positron emission tomography study. Psychiatry Res. 2015 Sep 30; 233(3):367-72. PMID: 26184458.
      View in: PubMed
    12. Nutt DJ, Rehm J, van den Brink W, Gorwood P, Buchsbaum M. Progress in mind: focus on alcohol use disorders, an elsevier resource centre. Psychiatry Res. 2015 Apr 30; 226(2-3):513-4. PMID: 25724487.
      View in: PubMed
    13. Balevich EC, Haznedar MM, Wang E, Newmark RE, Bloom R, Schneiderman JS, Aronowitz J, Tang CY, Chu KW, Byne W, Buchsbaum M, Hazlett EA. Corpus callosum size and diffusion tensor anisotropy in adolescents and adults with schizophrenia. Psychiatry Res. 2015 Mar 30; 231(3):244-51. PMID: 25637358; PMCID: PMC4363270.
    14. Zhang J, Chu KW, Teague EB, Newmark RE, Buchsbaum M. fMRI assessment of thalamocortical connectivity during attentional performance. Magn Reson Imaging. 2013 Sep; 31(7):1112-8. PMID: 23727467; PMCID: PMC3729917.
    15. Zhang J, Buchsbaum M, Chu KW, Hazlett EA. A manual, semi-automated and automated ROI study of fMRI hemodynamic response. Stud Health Technol Inform. 2013; 192:921. PMID: 23920695.
      View in: PubMed
    16. Lebedev A, Miraghaie R, Kotta K, Ball CE, Zhang J, Buchsbaum M, Kolb HC, Elizarov A. Batch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer. Lab Chip. 2013 Jan 07; 13(1):136-45. PMID: 23135409; PMCID: PMC3743669.
    17. Hazlett EA, Collazo T, Zelmanova Y, Entis JJ, Chu KW, Goldstein KE, Roussos P, Haznedar MM, Koenigsberg HW, New AS, Buchsbaum M, Hershowitz JP, Siever LJ, Byne W. Anterior limb of the internal capsule in schizotypal personality disorder: fiber-tract counting, volume, and anisotropy. Schizophr Res. 2012 Nov; 141(2-3):119-27. PMID: 22995934; PMCID: PMC3742803.
    18. Pichika R, Buchsbaum M, Bailer U, Hoh C, Decastro A, Buchsbaum BR, Kaye W. Serotonin transporter binding after recovery from bulimia nervosa. Int J Eat Disord. 2012 Apr; 45(3):345-52. PMID: 21671458; PMCID: PMC3175264.
    19. Mann SL, Hazlett EA, Byne W, Hof PR, Buchsbaum M, Cohen BH, Goldstein KE, Haznedar MM, Mitsis EM, Siever LJ, Chu KW. Anterior and posterior cingulate cortex volume in healthy adults: effects of aging and gender differences. Brain Res. 2011 Jul 15; 1401:18-29. PMID: 21669408; PMCID: PMC3134959.
    20. Schneiderman JS, Hazlett EA, Chu KW, Zhang J, Goodman CR, Newmark RE, Torosjan Y, Canfield EL, Entis J, Mitropoulou V, Tang CY, Friedman J, Buchsbaum M. Brodmann area analysis of white matter anisotropy and age in schizophrenia. Schizophr Res. 2011 Aug; 130(1-3):57-67. PMID: 21600737; PMCID: PMC3139821.
    21. Horga G, Bernacer J, Dusi N, Entis J, Chu K, Hazlett EA, Haznedar MM, Kemether E, Byne W, Buchsbaum M. Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2011 Oct; 261(7):467-76. PMID: 21431919; PMCID: PMC3182327.
    22. Lehrer DS, Christian BT, Kirbas C, Chiang M, Sidhu S, Short H, Wang B, Shi B, Chu KW, Merrill B, Buchsbaum M. 18F-fallypride binding potential in patients with schizophrenia compared to healthy controls. Schizophr Res. 2010 Sep; 122(1-3):43-52. PMID: 20655709; PMCID: PMC3278159.
    23. Pallanti S, Haznedar MM, Hollander E, Licalzi EM, Bernardi S, Newmark R, Buchsbaum M. Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study. Neuropsychobiology. 2010; 62(2):132-8. PMID: 20588072.
      View in: PubMed
    24. Mitelman SA, Canfield EL, Brickman AM, Shihabuddin L, Hazlett EA, Buchsbaum M. Progressive ventricular expansion in chronic poor-outcome schizophrenia. Cogn Behav Neurol. 2010 Jun; 23(2):85-8. PMID: 20535056.
      View in: PubMed
    25. Segal D, Haznedar MM, Hazlett EA, Entis JJ, Newmark RE, Torosjan Y, Schneiderman JS, Friedman J, Chu KW, Tang CY, Buchsbaum M, Hof PR. Diffusion tensor anisotropy in the cingulate gyrus in schizophrenia. Neuroimage. 2010 Apr 01; 50(2):357-65. PMID: 20045072.
      View in: PubMed
    26. Zhang J, Mitsis EM, Chu K, Newmark RE, Hazlett EA, Buchsbaum M. Statistical parametric mapping and cluster counting analysis of [18F] FDG-PET imaging in traumatic brain injury. J Neurotrauma. 2010 Jan; 27(1):35-49. PMID: 19715400.
      View in: PubMed
    27. New AS, Hazlett EA, Newmark RE, Zhang J, Triebwasser J, Meyerson D, Lazarus S, Trisdorfer R, Goldstein KE, Goodman M, Koenigsberg HW, Flory JD, Siever LJ, Buchsbaum M. Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder. Biol Psychiatry. 2009 Dec 15; 66(12):1107-14. PMID: 19748078; PMCID: PMC2788117.
    28. Mitelman SA, Nikiforova YK, Canfield EL, Hazlett EA, Brickman AM, Shihabuddin L, Buchsbaum M. A longitudinal study of the corpus callosum in chronic schizophrenia. Schizophr Res. 2009 Oct; 114(1-3):144-53. PMID: 19713080; PMCID: PMC2763416.
    29. Buchsbaum M, Haznedar M, Newmark RE, Chu KW, Dusi N, Entis JJ, Goldstein KE, Goodman CR, Gupta A, Hazlett E, Iannuzzi J, Torosjan Y, Zhang J, Wolkin A. FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia. Schizophr Res. 2009 Oct; 114(1-3):161-71. PMID: 19695836.
      View in: PubMed
    30. Mitelman SA, Canfield EL, Chu KW, Brickman AM, Shihabuddin L, Hazlett EA, Buchsbaum M. Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen. Schizophr Res. 2009 Sep; 113(2-3):241-5. PMID: 19616411; PMCID: PMC2763420.
    31. Goldstein KE, Hazlett EA, New AS, Haznedar MM, Newmark RE, Zelmanova Y, Passarelli V, Weinstein SR, Canfield EL, Meyerson DA, Tang CY, Buchsbaum M, Siever LJ. Smaller superior temporal gyrus volume specificity in schizotypal personality disorder. Schizophr Res. 2009 Jul; 112(1-3):14-23. PMID: 19473820; PMCID: PMC2782902.
    32. Mitelman SA, Canfield EL, Newmark RE, Brickman AM, Torosjan Y, Chu KW, Hazlett EA, Haznedar MM, Shihabuddin L, Buchsbaum M. [Not Available]. Open Neuroimag J. 2009 May 20; 3:31-47. PMID: 19547667.
      View in: PubMed
    33. Buchsbaum M. Evidence, evidence-based medicine, and evidence utility in psychiatry and electrophysiology. Clin EEG Neurosci. 2009 Apr; 40(2):143-5. PMID: 19534306.
      View in: PubMed
    34. Schneiderman JS, Buchsbaum M, Haznedar MM, Hazlett EA, Brickman AM, Shihabuddin L, Brand JG, Torosjan Y, Newmark RE, Canfield EL, Tang C, Aronowitz J, Paul-Odouard R, Hof PR. Age and diffusion tensor anisotropy in adolescent and adult patients with schizophrenia. Neuroimage. 2009 Apr 15; 45(3):662-71. PMID: 19168139; PMCID: PMC2677993.
    35. Yehuda R, Harvey PD, Golier JA, Newmark RE, Bowie CR, Wohltmann JJ, Grossman RA, Schmeidler J, Hazlett EA, Buchsbaum M. Changes in relative glucose metabolic rate following cortisol administration in aging veterans with posttraumatic stress disorder: an FDG-PET neuroimaging study. J Neuropsychiatry Clin Neurosci. 2009; 21(2):132-43. PMID: 19622684.
      View in: PubMed
    36. Hazlett EA, Byne W, Brickman AM, Mitsis EM, Newmark R, Haznedar MM, Knatz DT, Chen AD, Buchsbaum M. Effects of sex and normal aging on regional brain activation during verbal memory performance. Neurobiol Aging. 2010 May; 31(5):826-38. PMID: 19027195; PMCID: PMC2871327.
    37. Worthley SG, Zhang ZY, Machac J, Helft G, Tang C, Liew GY, Zaman AG, Worthley MI, Fayad ZA, Buchsbaum M, Fuster V, Badimon JJ. In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging. 2009 Mar; 25(3):251-7. PMID: 18979182.
      View in: PubMed
    38. Carpenter DM, Tang CY, Friedman JI, Hof PR, Stewart DG, Buchsbaum M, Harvey PD, Gorman JG, Davis KL. Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia. Neuroreport. 2008 Sep 17; 19(14):1369-72. PMID: 18766013; PMCID: PMC2653858.
    39. Hollander E, Buchsbaum M, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology. 2008; 58(1):37-47. PMID: 18781089.
      View in: PubMed
    40. Hazlett EA, Buchsbaum M, Zhang J, Newmark RE, Glanton CF, Zelmanova Y, Haznedar MM, Chu KW, Nenadic I, Kemether EM, Tang CY, New AS, Siever LJ. Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating. Neuroimage. 2008 Sep 01; 42(3):1164-77. PMID: 18588988; PMCID: PMC2548278.
    41. Byne W, Hazlett EA, Buchsbaum M, Kemether E. The thalamus and schizophrenia: current status of research. Acta Neuropathol. 2009 Apr; 117(4):347-68. PMID: 18604544.
      View in: PubMed
    42. Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagan L, Golembo S, Kanellopoulou I, Ng J, Hof PR, Harvey PD, Tsopelas ND, Stewart D, Davis KL. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry. 2008 Aug; 165(8):1024-32. PMID: 18558643.
      View in: PubMed
    43. Hazlett EA, Buchsbaum M, Haznedar MM, Newmark R, Goldstein KE, Zelmanova Y, Glanton CF, Torosjan Y, New AS, Lo JN, Mitropoulou V, Siever LJ. Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr Res. 2008 Apr; 101(1-3):111-23. PMID: 18272348; PMCID: PMC2672563.
    44. Wu JC, Gillin JC, Buchsbaum M, Schachat C, Darnall LA, Keator DB, Fallon JH, Bunney WE. Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression. J Affect Disord. 2008 Apr; 107(1-3):181-6. PMID: 18031825.
      View in: PubMed
    45. Mitelman SA, Buchsbaum M. Very poor outcome schizophrenia: clinical and neuroimaging aspects. Int Rev Psychiatry. 2007 Aug; 19(4):345-57. PMID: 17671868; PMCID: PMC2709451.
    46. Buchsbaum M, Buchsbaum BR, Hazlett EA, Haznedar MM, Newmark R, Tang CY, Hof PR. Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry. 2007 Jul; 164(7):1072-81. PMID: 17606659.
      View in: PubMed
    47. Schneiderman JS, Buchsbaum M, Haznedar MM, Hazlett EA, Brickman AM, Shihabuddin L, Brand JG, Torosjan Y, Newmark RE, Tang C, Aronowitz J, Paul-Odouard R, Byne W, Hof PR. Diffusion tensor anisotropy in adolescents and adults. Neuropsychobiology. 2007; 55(2):96-111. PMID: 17587876; PMCID: PMC2806688.
    48. Tang CY, Friedman J, Shungu D, Chang L, Ernst T, Stewart D, Hajianpour A, Carpenter D, Ng J, Mao X, Hof PR, Buchsbaum M, Davis K, Gorman JM. Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls. BMC Psychiatry. 2007 Jun 19; 7:25. PMID: 17578565; PMCID: PMC1929081.
    49. Buchsbaum M, Haznedar MM, Aronowitz J, Brickman AM, Newmark RE, Bloom R, Brand J, Goldstein KE, Heath D, Starson M, Hazlett EA. FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol. Schizophr Res. 2007 Aug; 94(1-3):293-305. PMID: 17574821.
      View in: PubMed
    50. Garakani A, Buchsbaum M, Newmark RE, Goodman C, Aaronson CJ, Martinez JM, Torosjan Y, Chu KW, Gorman JM. The effect of doxapram on brain imaging in patients with panic disorder. Eur Neuropsychopharmacol. 2007 Oct; 17(10):672-86. PMID: 17560768; PMCID: PMC2695988.
    51. Mitelman SA, Brickman AM, Shihabuddin L, Newmark RE, Hazlett EA, Haznedar MM, Buchsbaum M. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage. 2007 Aug 15; 37(2):449-62. PMID: 17587598; PMCID: PMC1994089.
    52. Hazlett EA, Romero MJ, Haznedar MM, New AS, Goldstein KE, Newmark RE, Siever LJ, Buchsbaum M. Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophr Res. 2007 Jul; 93(1-3):288-95. PMID: 17478083.
      View in: PubMed
    53. Yehuda R, Harvey PD, Buchsbaum M, Tischler L, Schmeidler J. Enhanced effects of cortisol administration on episodic and working memory in aging veterans with PTSD. Neuropsychopharmacology. 2007 Dec; 32(12):2581-91. PMID: 17392739.
      View in: PubMed
    54. Mitelman SA, Torosjan Y, Newmark RE, Schneiderman JS, Chu KW, Brickman AM, Haznedar MM, Hazlett EA, Tang CY, Shihabuddin L, Buchsbaum M. Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey. Schizophr Res. 2007 May; 92(1-3):211-24. PMID: 17329081.
      View in: PubMed
    55. New AS, Hazlett EA, Buchsbaum M, Goodman M, Mitelman SA, Newmark R, Trisdorfer R, Haznedar MM, Koenigsberg HW, Flory J, Siever LJ. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology. 2007 Jul; 32(7):1629-40. PMID: 17203018.
      View in: PubMed
    56. Buchsbaum M, Schoenknecht P, Torosjan Y, Newmark R, Chu KW, Mitelman S, Brickman AM, Shihabuddin L, Haznedar MM, Hazlett EA, Ahmed S, Tang C. Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Ann Gen Psychiatry. 2006 Nov 28; 5:19. PMID: 17132158; PMCID: PMC1687182.
    57. Mitelman SA, Byne W, Kemether EM, Newmark RE, Hazlett EA, Haznedar MM, Buchsbaum M. Metabolic thalamocortical correlations during a verbal learning task and their comparison with correlations among regional volumes. Brain Res. 2006 Oct 09; 1114(1):125-37. PMID: 16935269.
      View in: PubMed
    58. Buchsbaum M, Friedman J, Buchsbaum BR, Chu KW, Hazlett EA, Newmark R, Schneiderman JS, Torosjan Y, Tang C, Hof PR, Stewart D, Davis KL, Gorman J. Diffusion tensor imaging in schizophrenia. Biol Psychiatry. 2006 Dec 01; 60(11):1181-7. PMID: 16893533.
      View in: PubMed
    59. Wu JC, Gillin JC, Buchsbaum M, Chen P, Keator DB, Khosla Wu N, Darnall LA, Fallon JH, Bunney WE. Frontal lobe metabolic decreases with sleep deprivation not totally reversed by recovery sleep. Neuropsychopharmacology. 2006 Dec; 31(12):2783-92. PMID: 16880772.
      View in: PubMed
    60. Buchsbaum M, Buchsbaum BR, Chokron S, Tang C, Wei TC, Byne W. Thalamocortical circuits: fMRI assessment of the pulvinar and medial dorsal nucleus in normal volunteers. Neurosci Lett. 2006 Sep 01; 404(3):282-7. PMID: 16860474.
      View in: PubMed
    61. Mitelman SA, Newmark RE, Torosjan Y, Chu KW, Brickman AM, Haznedar MM, Hazlett EA, Tang CY, Shihabuddin L, Buchsbaum M. White matter fractional anisotropy and outcome in schizophrenia. Schizophr Res. 2006 Oct; 87(1-3):138-59. PMID: 16854563.
      View in: PubMed
    62. Haznedar MM, Buchsbaum M, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry. 2006 Jul; 163(7):1252-63. PMID: 16816232.
      View in: PubMed
    63. Tischler L, Brand SR, Stavitsky K, Labinsky E, Newmark R, Grossman R, Buchsbaum M, Yehuda R. The relationship between hippocampal volume and declarative memory in a population of combat veterans with and without PTSD. Ann N Y Acad Sci. 2006 Jul; 1071:405-9. PMID: 16891587.
      View in: PubMed
    64. Byne W, Kidkardnee S, Tatusov A, Yiannoulos G, Buchsbaum M, Haroutunian V. Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr Res. 2006 Jul; 85(1-3):245-53. PMID: 16730162.
      View in: PubMed
    65. Zhang Z, Machac J, Helft G, Worthley SG, Tang C, Zaman AG, Rodriguez OJ, Buchsbaum M, Fuster V, Badimon JJ. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med. 2006 May 25; 6:3. PMID: 16725052; PMCID: PMC1479805.
    66. Buchsbaum M, Christian BT, Lehrer DS, Narayanan TK, Shi B, Mantil J, Kemether E, Oakes TR, Mukherjee J. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophr Res. 2006 Jul; 85(1-3):232-44. PMID: 16713185.
      View in: PubMed
    67. Buchsbaum M, Hollander E, Pallanti S, Baldini Rossi N, Platholi J, Newmark R, Bloom R, Sood E. Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patients. Neuropsychobiology. 2006; 53(3):157-68. PMID: 16707915.
      View in: PubMed
    68. Christian BT, Lehrer DS, Shi B, Narayanan TK, Strohmeyer PS, Buchsbaum M, Mantil JC. Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task. Neuroimage. 2006 May 15; 31(1):139-52. PMID: 16469510.
      View in: PubMed
    69. Yehuda R, Golier JA, Tischler L, Harvey PD, Newmark R, Yang RK, Buchsbaum M. Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors. J Psychiatr Res. 2007 Aug; 41(5):435-45. PMID: 16445942.
      View in: PubMed
    70. Brickman AM, Buchsbaum M, Ivanov Z, Borod JC, Foldi NS, Hahn E, Mitelman SA, Hazlett EA, Lincoln SJ, Newmark RE, Shihabuddin L. Internal capsule size in good-outcome and poor-outcome schizophrenia. J Neuropsychiatry Clin Neurosci. 2006; 18(3):364-76. PMID: 16963586.
      View in: PubMed
    71. Yehuda R, Yang RK, Buchsbaum M, Golier JA. Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD. Psychoneuroendocrinology. 2006 May; 31(4):447-51. PMID: 16364555.
      View in: PubMed
    72. Wasserstein MP, Snyderman SE, Sansaricq C, Buchsbaum M. Cerebral glucose metabolism in adults with early treated classic phenylketonuria. Mol Genet Metab. 2006 Mar; 87(3):272-7. PMID: 16343970.
      View in: PubMed
    73. Mitelman SA, Buchsbaum M, Brickman AM, Shihabuddin L. Cortical intercorrelations of frontal area volumes in schizophrenia. Neuroimage. 2005 Oct 01; 27(4):753-70. PMID: 15990338.
      View in: PubMed
    74. Mitelman SA, Byne W, Kemether EM, Hazlett EA, Buchsbaum M. Correlations between volumes of the pulvinar, centromedian, and mediodorsal nuclei and cortical Brodmann's areas in schizophrenia. Neurosci Lett. 2006 Jan 09; 392(1-2):16-21. PMID: 16171947.
      View in: PubMed
    75. Mitelman SA, Byne W, Kemether EM, Hazlett EA, Buchsbaum M. Metabolic disconnection between the mediodorsal nucleus of the thalamus and cortical Brodmann's areas of the left hemisphere in schizophrenia. Am J Psychiatry. 2005 Sep; 162(9):1733-5. PMID: 16135634.
      View in: PubMed
    76. Hollander E, Anagnostou E, Chaplin W, Esposito K, Haznedar MM, Licalzi E, Wasserman S, Soorya L, Buchsbaum M. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry. 2005 Aug 01; 58(3):226-32. PMID: 15939406.
      View in: PubMed
    77. Mitelman SA, Shihabuddin L, Brickman AM, Buchsbaum M. Cortical intercorrelations of temporal area volumes in schizophrenia. Schizophr Res. 2005 Jul 15; 76(2-3):207-29. PMID: 15949654.
      View in: PubMed
    78. Hazlett EA, New AS, Newmark R, Haznedar MM, Lo JN, Speiser LJ, Chen AD, Mitropoulou V, Minzenberg M, Siever LJ, Buchsbaum M. Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry. 2005 Oct 15; 58(8):614-23. PMID: 15993861.
      View in: PubMed
    79. Koenigsberg HW, Buchsbaum M, Buchsbaum BR, Schneiderman JS, Tang CY, New A, Goodman M, Siever LJ. Functional MRI of visuospatial working memory in schizotypal personality disorder: a region-of-interest analysis. Psychol Med. 2005 Jul; 35(7):1019-30. PMID: 16045068.
      View in: PubMed
    80. Lehrer DS, Christian BT, Mantil J, Murray AC, Buchsbaum BR, Oakes TR, Byne W, Kemether EM, Buchsbaum M. Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia. Am J Psychiatry. 2005 May; 162(5):931-8. PMID: 15863795.
      View in: PubMed
    81. Haznedar MM, Roversi F, Pallanti S, Baldini-Rossi N, Schnur DB, Licalzi EM, Tang C, Hof PR, Hollander E, Buchsbaum M. Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Biol Psychiatry. 2005 Apr 01; 57(7):733-42. PMID: 15820230.
      View in: PubMed
    82. Hollander E, Pallanti S, Baldini Rossi N, Sood E, Baker BR, Buchsbaum M. Imaging monetary reward in pathological gamblers. World J Biol Psychiatry. 2005; 6(2):113-20. PMID: 16156484.
      View in: PubMed
    83. Mitelman SA, Shihabuddin L, Brickman AM, Hazlett EA, Buchsbaum M. Volume of the cingulate and outcome in schizophrenia. Schizophr Res. 2005 Jan 01; 72(2-3):91-108. PMID: 15560955.
      View in: PubMed
    84. Mitelman SA, Brickman AM, Shihabuddin L, Newmark R, Chu KW, Buchsbaum M. Correlations between MRI-assessed volumes of the thalamus and cortical Brodmann's areas in schizophrenia. Schizophr Res. 2005 Jun 15; 75(2-3):265-81. PMID: 15885518.
      View in: PubMed
    85. Haznedar MM, Buchsbaum M, Hazlett EA, Shihabuddin L, New A, Siever LJ. Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res. 2004 Dec 01; 71(2-3):249-62. PMID: 15474896.
      View in: PubMed
    86. Tamminga CA, Buchsbaum M. Frontal cortex function. Am J Psychiatry. 2004 Dec; 161(12):2178. PMID: 15569885.
      View in: PubMed
    87. Brickman AM, Buchsbaum M, Shihabuddin L, Byne W, Newmark RE, Brand J, Ahmed S, Mitelman SA, Hazlett EA. Thalamus size and outcome in schizophrenia. Schizophr Res. 2004 Dec 01; 71(2-3):473-84. PMID: 15474918.
      View in: PubMed
    88. Brickman AM, Buchsbaum M, Bloom R, Bokhoven P, Paul-Odouard R, Haznedar MM, Dahlman KL, Hazlett EA, Aronowitz J, Heath D, Shihabuddin L. Neuropsychological functioning in first-break, never-medicated adolescents with psychosis. J Nerv Ment Dis. 2004 Sep; 192(9):615-22. PMID: 15348978.
      View in: PubMed
    89. Schulz KP, Fan J, Tang CY, Newcorn JH, Buchsbaum M, Cheung AM, Halperin JM. Response inhibition in adolescents diagnosed with attention deficit hyperactivity disorder during childhood: an event-related FMRI study. Am J Psychiatry. 2004 Sep; 161(9):1650-7. PMID: 15337656.
      View in: PubMed
    90. New AS, Buchsbaum M, Hazlett EA, Goodman M, Koenigsberg HW, Lo J, Iskander L, Newmark R, Brand J, O'Flynn K, Siever LJ. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl). 2004 Nov; 176(3-4):451-8. PMID: 15160265.
      View in: PubMed
    91. Hazlett EA, Buchsbaum M, Kemether E, Bloom R, Platholi J, Brickman AM, Shihabuddin L, Tang C, Byne W. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am J Psychiatry. 2004 Feb; 161(2):305-14. PMID: 14754780.
      View in: PubMed
    92. Gaser C, Nenadic I, Buchsbaum BR, Hazlett EA, Buchsbaum M. Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex. Am J Psychiatry. 2004 Jan; 161(1):154-6. PMID: 14702264.
      View in: PubMed
    93. Hazlett EA, Buchsbaum M, Hsieh P, Haznedar MM, Platholi J, LiCalzi EM, Cartwright C, Hollander E. Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patients. Neuropsychobiology. 2004; 49(3):115-25. PMID: 15034226.
      View in: PubMed
    94. Mitelman SA, Shihabuddin L, Brickman AM, Hazlett EA, Buchsbaum M. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. Am J Psychiatry. 2003 Dec; 160(12):2154-68. PMID: 14638586.
      View in: PubMed
    95. Chokron S, Bartolomeo P, Colliot P, Brickman AM, Tabert M, Wei T, Buchsbaum M. Selective attention, inhibition for repeated events and hemispheric specialization. Brain Cogn. 2003 Nov; 53(2):158-61. PMID: 14607138.
      View in: PubMed
    96. Buchsbaum M, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, Davis K. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res. 2003 Nov 01; 64(1):53-62. PMID: 14511801.
      View in: PubMed
    97. Kemether EM, Buchsbaum M, Byne W, Hazlett EA, Haznedar M, Brickman AM, Platholi J, Bloom R. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch Gen Psychiatry. 2003 Oct; 60(10):983-91. PMID: 14557143.
      View in: PubMed
    98. Hazlett EA, Levine J, Buchsbaum M, Silverman JM, New A, Sevin EM, Maldari LA, Siever LJ. Deficient attentional modulation of the startle response in patients with schizotypal personality disorder. Am J Psychiatry. 2003 Sep; 160(9):1621-6. PMID: 12944337.
      View in: PubMed
    99. Brickman AM, Buchsbaum M, Shihabuddin L, Hazlett EA, Borod JC, Mohs RC. Striatal size, glucose metabolic rate, and verbal learning in normal aging. Brain Res Cogn Brain Res. 2003 Jun; 17(1):106-16. PMID: 12763197.
      View in: PubMed
    100. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry. 2003 May; 60(5):443-56. PMID: 12742865.
      View in: PubMed
    101. Buchsbaum M. Regional cerebral blood flow changes in drug-resistant depressed patients following treatment with transcranial magnetic stimulation: a statistical parametric mapping analysis. Psychiatry Res. 2002 Aug 20; 115(1-2):91. PMID: 12233711.
      View in: PubMed
    102. New AS, Hazlett EA, Buchsbaum M, Goodman M, Reynolds D, Mitropoulou V, Sprung L, Shaw RB, Koenigsberg H, Platholi J, Silverman J, Siever LJ. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry. 2002 Jul; 59(7):621-9. PMID: 12090815.
      View in: PubMed
    103. Grossman R, Buchsbaum M, Yehuda R. Neuroimaging studies in post-traumatic stress disorder. Psychiatr Clin North Am. 2002 Jun; 25(2):317-40, vi. PMID: 12136503.
      View in: PubMed
    104. Buchsbaum M, Shihabuddin L, Hazlett EA, Schröder J, Haznedar MM, Powchik P, Spiegel-Cohen J, Wei T, Singer MB, Davis KL. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate. Schizophr Res. 2002 May 01; 55(1-2):25-40. PMID: 11955961.
      View in: PubMed
    105. Siever LJ, Koenigsberg HW, Harvey P, Mitropoulou V, Laruelle M, Abi-Dargham A, Goodman M, Buchsbaum M. Cognitive and brain function in schizotypal personality disorder. Schizophr Res. 2002 Mar 01; 54(1-2):157-67. PMID: 11853990.
      View in: PubMed
    106. Buchsbaum M, Nenadic I, Hazlett EA, Spiegel-Cohen J, Fleischman MB, Akhavan A, Silverman JM, Siever LJ. Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res. 2002 Mar 01; 54(1-2):141-50. PMID: 11853988.
      View in: PubMed
    107. Byne W, Buchsbaum M, Mattiace LA, Hazlett EA, Kemether E, Elhakem SL, Purohit DP, Haroutunian V, Jones L. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry. 2002 Jan; 159(1):59-65. PMID: 11772691.
      View in: PubMed
    108. Buchsbaum M, Hazlett EA, Wu J, Bunney WE. Positron emission tomography with deoxyglucose-F18 imaging of sleep. Neuropsychopharmacology. 2001 Nov; 25(5 Suppl):S50-6. PMID: 11682274.
      View in: PubMed
    109. Shihabuddin L, Buchsbaum M, Hazlett EA, Silverman J, New A, Brickman AM, Mitropoulou V, Nunn M, Fleischman MB, Tang C, Siever LJ. Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry. 2001 Sep; 58(9):877-84. PMID: 11545672.
      View in: PubMed
    110. Byne W, Tobet S, Mattiace LA, Lasco MS, Kemether E, Edgar MA, Morgello S, Buchsbaum M, Jones LB. The interstitial nuclei of the human anterior hypothalamus: an investigation of variation with sex, sexual orientation, and HIV status. Horm Behav. 2001 Sep; 40(2):86-92. PMID: 11534967.
      View in: PubMed
    111. Hazlett EA, Buchsbaum M. Sensorimotor gating deficits and hypofrontality in schizophrenia. Front Biosci. 2001 Sep 01; 6:D1069-72. PMID: 11532605.
      View in: PubMed
    112. Hazlett EA, Buchsbaum M, Tang CY, Fleischman MB, Wei TC, Byne W, Haznedar MM. Thalamic activation during an attention-to-prepulse startle modification paradigm: a functional MRI study. Biol Psychiatry. 2001 Aug 15; 50(4):281-91. PMID: 11522263.
      View in: PubMed
    113. Gaser C, Nenadic I, Buchsbaum BR, Hazlett EA, Buchsbaum M. Deformation-based morphometry and its relation to conventional volumetry of brain lateral ventricles in MRI. Neuroimage. 2001 Jun; 13(6 Pt 1):1140-5. PMID: 11352619.
      View in: PubMed
    114. Buchsbaum M, Hollander E, Haznedar MM, Tang C, Spiegel-Cohen J, Wei TC, Solimando A, Buchsbaum BR, Robins D, Bienstock C, Cartwright C, Mosovich S. Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. Int J Neuropsychopharmacol. 2001 Jun; 4(2):119-25. PMID: 11466160.
      View in: PubMed
    115. Downhill JE, Buchsbaum M, Hazlett EA, Barth S, Lees Roitman S, Nunn M, Lekarev O, Wei T, Shihabuddin L, Mitropoulou V, Silverman J, Siever LJ. Temporal lobe volume determined by magnetic resonance imaging in schizotypal personality disorder and schizophrenia. Schizophr Res. 2001 Mar 30; 48(2-3):187-99. PMID: 11295372.
      View in: PubMed
    116. Schröder J, Buchsbaum M, Shihabuddin L, Tang C, Wei TC, Spiegel-Cohen J, Hazlett EA, Abel L, Luu-Hsia C, Ciaravolo TM, Marin D, Davis KL. Patterns of cortical activity and memory performance in Alzheimer's disease. Biol Psychiatry. 2001 Mar 01; 49(5):426-36. PMID: 11274654.
      View in: PubMed
    117. Byne W, Buchsbaum M, Kemether E, Hazlett EA, Shinwari A, Mitropoulou V, Siever LJ. Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch Gen Psychiatry. 2001 Feb; 58(2):133-40. PMID: 11177115.
      View in: PubMed
    118. Nusbaum AO, Tang CY, Buchsbaum M, Wei TC, Atlas SW. Regional and global changes in cerebral diffusion with normal aging. AJNR Am J Neuroradiol. 2001 Jan; 22(1):136-42. PMID: 11158899.
      View in: PubMed
    119. Danos P, Guich S, Abel L, Buchsbaum M. Eeg alpha rhythm and glucose metabolic rate in the thalamus in schizophrenia. Neuropsychobiology. 2001; 43(4):265-72. PMID: 11340367.
      View in: PubMed
    120. Tabert MH, Borod JC, Tang CY, Lange G, Wei TC, Johnson R, Nusbaum AO, Buchsbaum M. Differential amygdala activation during emotional decision and recognition memory tasks using unpleasant words: an fMRI study. Neuropsychologia. 2001; 39(6):556-73. PMID: 11257281.
      View in: PubMed
    121. Gottschalk LA, Fronczek J, Abel L, Buchsbaum M, Fallon JH. The cerebral neurobiology of anxiety, anxiety displacement, and anxiety denial. Psychother Psychosom. 2001 Jan-Feb; 70(1):17-24. PMID: 11150934.
      View in: PubMed
    122. Haznedar MM, Buchsbaum M, Wei TC, Hof PR, Cartwright C, Bienstock CA, Hollander E. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am J Psychiatry. 2000 Dec; 157(12):1994-2001. PMID: 11097966.
      View in: PubMed
    123. Simeon D, Guralnik O, Hazlett EA, Spiegel-Cohen J, Hollander E, Buchsbaum M. Feeling unreal: a PET study of depersonalization disorder. Am J Psychiatry. 2000 Nov; 157(11):1782-8. PMID: 11058475.
      View in: PubMed
    124. Tabert MH, Chokron S, Tang CY, Wei T, Brickman AM, Buchsbaum M. Visual target detection paradigm for the study of selective attention. Brain Res Brain Res Protoc. 2000 Nov; 6(1-2):80-5. PMID: 11086266.
      View in: PubMed
    125. Hazlett EA, Buchsbaum M, Jeu LA, Nenadic I, Fleischman MB, Shihabuddin L, Haznedar MM, Harvey PD. Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task. Schizophr Res. 2000 May 25; 43(1):33-46. PMID: 10828413.
      View in: PubMed
    126. Downhill JE, Buchsbaum M, Wei T, Spiegel-Cohen J, Hazlett EA, Haznedar MM, Silverman J, Siever LJ. Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder. Schizophr Res. 2000 May 05; 42(3):193-208. PMID: 10785578.
      View in: PubMed
    127. Nusbaum AO, Tang CY, Wei T, Buchsbaum M, Atlas SW. Whole-brain diffusion MR histograms differ between MS subtypes. Neurology. 2000 Apr 11; 54(7):1421-7. PMID: 10751250.
      View in: PubMed
    128. Chokron S, Brickman AM, Wei T, Buchsbaum M. Hemispheric asymmetry for selective attention. Brain Res Cogn Brain Res. 2000 Jan; 9(1):85-90. PMID: 10666560.
      View in: PubMed
    129. Wu J, Buchsbaum M, Gillin JC, Tang C, Cadwell S, Wiegand M, Najafi A, Klein E, Hazen K, Bunney WE, Fallon JH, Keator D. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry. 1999 Aug; 156(8):1149-58. PMID: 10450253.
      View in: PubMed
    130. Hazlett EA, Buchsbaum M, Byne W, Wei TC, Spiegel-Cohen J, Geneve C, Kinderlehrer R, Haznedar MM, Shihabuddin L, Siever LJ. Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry. 1999 Aug; 156(8):1190-9. PMID: 10450259.
      View in: PubMed
    131. Siever LJ, Buchsbaum M, New AS, Spiegel-Cohen J, Wei T, Hazlett EA, Sevin E, Nunn M, Mitropoulou V. d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology. 1999 May; 20(5):413-23. PMID: 10192822.
      View in: PubMed
    132. Buchsbaum M, Hazlett EA, Haznedar MM, Spiegel-Cohen J, Wei TC. Visualizing fronto-striatal circuitry and neuroleptic effects in schizophrenia. Acta Psychiatr Scand Suppl. 1999; 395:129-37. PMID: 10225342.
      View in: PubMed
    133. Buchsbaum M, Fallon JH, Wei TC, Guich S, Spiegel-Cohen J, Hamilton M, Tang C. A method of basal forebrain anatomical standardization for functional image analysis. Psychiatry Res. 1998 Dec 14; 84(2-3):113-25. PMID: 10710168.
      View in: PubMed
    134. Hazlett EA, Buchsbaum M, Mohs RC, Spiegel-Cohen J, Wei TC, Azueta R, Haznedar MM, Singer MB, Shihabuddin L, Luu-Hsia C, Harvey PD. Age-related shift in brain region activity during successful memory performance. Neurobiol Aging. 1998 Sep-Oct; 19(5):437-45. PMID: 9880046.
      View in: PubMed
    135. Davis KL, Buchsbaum M, Shihabuddin L, Spiegel-Cohen J, Metzger M, Frecska E, Keefe RS, Powchik P. Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry. 1998 Jun 01; 43(11):783-93. PMID: 9611667.
      View in: PubMed
    136. Hazlett EA, Buchsbaum M, Haznedar MM, Singer MB, Germans MK, Schnur DB, Jimenez EA, Buchsbaum BR, Troyer BT. Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology. 1998 Mar; 35(2):186-98. PMID: 9529945.
      View in: PubMed
    137. Shihabuddin L, Buchsbaum M, Hazlett EA, Haznedar MM, Harvey PD, Newman A, Schnur DB, Spiegel-Cohen J, Wei T, Machac J, Knesaurek K, Vallabhajosula S, Biren MA, Ciaravolo TM, Luu-Hsia C. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch Gen Psychiatry. 1998 Mar; 55(3):235-43. PMID: 9510217.
      View in: PubMed
    138. Buchsbaum M, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA, Downhill J, Haznedar M, Fallon JH, Atlas SW. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport. 1998 Feb 16; 9(3):425-30. PMID: 9512384.
      View in: PubMed
    139. Stein DJ, Buchsbaum M, Hof PR, Siegel BV, Shihabuddin L. Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease. Neuropsychobiology. 1998; 37(1):10-9. PMID: 9438267.
      View in: PubMed
    140. Buchsbaum M, Hazlett EA. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull. 1998; 24(3):343-64. PMID: 9718628.
      View in: PubMed
    141. Raine A, Meloy JR, Bihrle S, Stoddard J, LaCasse L, Buchsbaum M. Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. Behav Sci Law. 1998; 16(3):319-32. PMID: 9768464.
      View in: PubMed
    142. Snyder SL, Buchsbaum M, Krishna RC. Unusual visual symptoms and Ganser-like state due to cerebral injury: a case study using (18)F-deoxyglucose positron emission tomography. Behav Neurol. 1998; 11(1):51-54. PMID: 11568402.
      View in: PubMed
    143. Buchsbaum M, Hazlett EA. Functional brain imaging and aging in schizophrenia. Schizophr Res. 1997 Oct 30; 27(2-3):129-41. PMID: 9416643.
      View in: PubMed
    144. Buchsbaum M, Trestman RL, Hazlett E, Siegel BV, Schaefer CH, Luu-Hsia C, Tang C, Herrera S, Solimando AC, Losonczy M, Serby M, Silverman J, Siever LJ. Regional cerebral blood flow during the Wisconsin Card Sort Test in schizotypal personality disorder. Schizophr Res. 1997 Oct 17; 27(1):21-8. PMID: 9373891.
      View in: PubMed
    145. Buchsbaum M, Yang S, Hazlett E, Siegel BV, Germans M, Haznedar M, O'Flaithbheartaigh S, Wei T, Silverman J, Siever LJ. Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging. Schizophr Res. 1997 Oct 17; 27(1):45-53. PMID: 9373894.
      View in: PubMed
    146. Haznedar MM, Buchsbaum M, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E. Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry. 1997 Aug; 154(8):1047-50. PMID: 9247387.
      View in: PubMed
    147. Haznedar MM, Buchsbaum M, Luu C, Hazlett EA, Siegel BV, Lohr J, Wu J, Haier RJ, Bunney WE. Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry. 1997 May; 154(5):682-4. PMID: 9137127.
      View in: PubMed
    148. Buchsbaum M, Wu J, Siegel BV, Hackett E, Trenary M, Abel L, Reynolds C. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry. 1997 Jan 01; 41(1):15-22. PMID: 8988791.
      View in: PubMed
    149. Gillin JC, Buchsbaum M, Valladares-Neto DC, Hong CC, Hazlett E, Langer SZ, Wu J. Effects of zolpidem on local cerebral glucose metabolism during non-REM sleep in normal volunteers: a positron emission tomography study. Neuropsychopharmacology. 1996 Sep; 15(3):302-13. PMID: 8873114.
      View in: PubMed
    150. Shihabuddin L, Silverman JM, Buchsbaum M, Seiver LJ, Luu C, Germans MK, Metzger M, Mohs RC, Smith CJ, Spiegel-Cohen J, Davis KL. Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigree. Mol Psychiatry. 1996 Jul; 1(3):215-22. PMID: 9118345.
      View in: PubMed
    151. Ho AP, Gillin JC, Buchsbaum M, Wu JC, Abel L, Bunney WE. Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study. Arch Gen Psychiatry. 1996 Jul; 53(7):645-52. PMID: 8660131.
      View in: PubMed
    152. Knesaurek K, Machac J, Vallabhajosula S, Buchsbaum M. A new iterative reconstruction technique for attenuation correction in high-resolution positron emission tomography. Eur J Nucl Med. 1996 Jun; 23(6):656-61. PMID: 8662099.
      View in: PubMed
    153. Hong CC, Jin Y, Potkin SG, Buchsbaum M, Wu J, Callaghan GM, Nudleman KL, Gillin JC. Language in dreaming and regional EEG alpha power. Sleep. 1996 Apr; 19(3):232-5. PMID: 8723382.
      View in: PubMed
    154. Schroder J, Buchsbaum M, Siegel BV, Geider FJ, Lohr J, Tang C, Wu J, Potkin SG. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res. 1996 Mar; 19(1):41-53. PMID: 9147495.
      View in: PubMed
    155. Buchsbaum M, Someya T, Teng CY, Abel L, Chin S, Najafi A, Haier RJ, Wu J, Bunney WE. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry. 1996 Feb; 153(2):191-9. PMID: 8561198.
      View in: PubMed
    156. Katz M, Buchsbaum M, Siegel BV, Wu J, Haier RJ, Bunney WE. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology. 1996; 33(1):1-11. PMID: 8821368.
      View in: PubMed
    157. Siegel BV, Shihabuddin L, Buchsbaum M, Starr A, Haier RJ, Valladares Neto DC. Gender differences in cortical glucose metabolism in Alzheimer's disease and normal aging. J Neuropsychiatry Clin Neurosci. 1996; 8(2):211-4. PMID: 9081560.
      View in: PubMed
    158. Hoffmann RE, Buchsbaum M, Jensen RV, Guich SM, Tsai K, Nuechterlein KH. Dimensional complexity of EEG waveforms in neuroleptic-free schizophrenic patients and normal control subjects. J Neuropsychiatry Clin Neurosci. 1996; 8(4):436-41. PMID: 9116481.
      View in: PubMed
    159. Siegel BV, Nuechterlein KH, Abel L, Wu JC, Buchsbaum M. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Schizophr Res. 1995 Sep; 17(1):85-94. PMID: 8541254.
      View in: PubMed
    160. Hong CC, Gillin JC, Dow BM, Wu J, Buchsbaum M. Localized and lateralized cerebral glucose metabolism associated with eye movements during REM sleep and wakefulness: a positron emission tomography (PET) study. Sleep. 1995 Sep; 18(7):570-80. PMID: 8552928.
      View in: PubMed
    161. Gillin JC, Ho AP, Buchsbaum M, Wu J, Abel L, Bunney WE. Functional brain imaging, sleep, and sleep deprivation: contributions to the "overarousal" hypothesis of depression. Acta Neuropsychiatr. 1995 Jun; 7(2):33-4. PMID: 26965345.
      View in: PubMed
    162. Valladares-Neto DC, Buchsbaum M, Evans WJ, Nguyen D, Nguyen P, Siegel BV, Stanley J, Starr A, Guich S, Rice D. EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease. Neuropsychobiology. 1995; 31(4):173-81. PMID: 7659198.
      View in: PubMed
    163. Buchsbaum M. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness. Clin Neurosci. 1995; 3(2):122-30. PMID: 7583618.
      View in: PubMed
    164. Schröder J, Buchsbaum M, Siegel BV, Geider FJ, Niethammer R. Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology. 1995; 28(1):38-45. PMID: 7871119.
      View in: PubMed
    165. Schroeder J, Buchsbaum M, Siegel BV, Geider FJ, Haier RJ, Lohr J, Wu J, Potkin SG. Patterns of cortical activity in schizophrenia. Psychol Med. 1994 Nov; 24(4):947-55. PMID: 7892362.
      View in: PubMed
    166. Raine A, Buchsbaum M, Stanley J, Lottenberg S, Abel L, Stoddard J. Selective reductions in prefrontal glucose metabolism in murderers. Biol Psychiatry. 1994 Sep 15; 36(6):365-73. PMID: 7803597.
      View in: PubMed
    167. Potkin SG, Buchsbaum M, Jin Y, Tang C, Telford J, Friedman G, Lottenberg S, Najafi A, Gulasekaram B, Costa J. Clozapine effects on glucose metabolic rate in striatum and frontal cortex. J Clin Psychiatry. 1994 Sep; 55 Suppl B:63-6. PMID: 7961576.
      View in: PubMed
    168. Ruff RM, Crouch JA, Tröster AI, Marshall LF, Buchsbaum M, Lottenberg S, Somers LM. Selected cases of poor outcome following a minor brain trauma: comparing neuropsychological and positron emission tomography assessment. Brain Inj. 1994 May-Jun; 8(4):297-308. PMID: 8081345.
      View in: PubMed
    169. Siegel BV, Buchsbaum M, Bunney WE, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry. 1993 Sep; 150(9):1325-36. PMID: 8352343.
      View in: PubMed
    170. Gottschalk LA, Fronczek J, Buchsbaum M. The cerebral neurobiology of hope and hopelessness. Psychiatry. 1993 Aug; 56(3):270-81. PMID: 8416007.
      View in: PubMed
    171. Wu JC, Buchsbaum M, Johnson JC, Hershey TG, Wagner EA, Teng C, Lottenberg S. Magnetic resonance and positron emission tomography imaging of the corpus callosum: size, shape and metabolic rate in unipolar depression. J Affect Disord. 1993 May; 28(1):15-25. PMID: 8326077.
      View in: PubMed
    172. Wu J, Buchsbaum M, Moy K, Denlea N, Kesslak P, Tseng H, Plosnaj D, Hetu M, Potkin S, Bracha S. Olfactory memory in unmedicated schizophrenics. Schizophr Res. 1993 Mar; 9(1):41-7. PMID: 8068050.
      View in: PubMed
    173. Hazlett EA, Dawson ME, Buchsbaum M, Nuechterlein KH. Reduced regional brain glucose metabolism assessed by positron emission tomography in electrodermal nonresponder schizophrenics: a pilot study. J Abnorm Psychol. 1993 Feb; 102(1):39-46. PMID: 8436698.
      View in: PubMed
    174. Buchsbaum M, Potkin SG, Siegel BV, Lohr J, Katz M, Gottschalk LA, Gulasekaram B, Marshall JF, Lottenberg S, Teng CY. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry. 1992 Dec; 49(12):966-74. PMID: 1449383.
      View in: PubMed
    175. Buchsbaum M, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry. 1992 Dec; 49(12):935-42. PMID: 1360198.
      View in: PubMed
    176. Gottschalk LA, Fronczek J, Abel L, Buchsbaum M. The relationship between social alienation and disorganized thinking in normal subjects and localized cerebral glucose metabolic rates assessed by positron emission tomography. Compr Psychiatry. 1992 Sep-Oct; 33(5):332-41. PMID: 1395553.
      View in: PubMed
    177. Buchsbaum M. Commentary on "The current status of PET scanning with respect to schizophrenia". Neuropsychopharmacology. 1992 Aug; 7(1):67-8; discussion 73-5. PMID: 1355970.
      View in: PubMed
    178. Buchsbaum M, Mansour CS, Teng DG, Zia AD, Siegel BV, Rice DM. Adolescent developmental change in topography of EEG amplitude. Schizophr Res. 1992 Jul; 7(2):101-7. PMID: 1515370.
      View in: PubMed
    179. Hagman JO, Wood F, Buchsbaum M, Tallal P, Flowers L, Katz W. Cerebral brain metabolism in adult dyslexic subjects assessed with positron emission tomography during performance of an auditory task. Arch Neurol. 1992 Jul; 49(7):734-9. PMID: 1497500.
      View in: PubMed
    180. Buchsbaum M, Potkin SG, Marshall JF, Lottenberg S, Teng C, Heh CW, Tafalla R, Reynolds C, Abel L, Plon L. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Neuropsychopharmacology. 1992 May; 6(3):155-63. PMID: 1599606.
      View in: PubMed
    181. Wu JC, Gillin JC, Buchsbaum M, Hershey T, Johnson JC, Bunney WE. Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry. 1992 Apr; 149(4):538-43. PMID: 1554042.
      View in: PubMed
    182. Buchsbaum M, Siegel BV, Wu JC, Hazlett E, Sicotte N, Haier R, Tanguay P, Asarnow R, Cadorette T, Donoghue D. Brief report: attention performance in autism and regional brain metabolic rate assessed by positron emission tomography. J Autism Dev Disord. 1992 Mar; 22(1):115-25. PMID: 1592761.
      View in: PubMed
    183. Haier RJ, Siegel BV, MacLachlan A, Soderling E, Lottenberg S, Buchsbaum M. Regional glucose metabolic changes after learning a complex visuospatial/motor task: a positron emission tomographic study. Brain Res. 1992 Jan 20; 570(1-2):134-43. PMID: 1617405.
      View in: PubMed
    184. Siegel BV, Asarnow R, Tanguay P, Call JD, Abel L, Ho A, Lott I, Buchsbaum M. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism. J Neuropsychiatry Clin Neurosci. 1992; 4(4):406-14. PMID: 1422167.
      View in: PubMed
    185. Buchsbaum M, Potkin S, Siegel B, Bunney WE, Lohr J, Katz M, Gottschalk L, Lottenberg S, Teng C, Abel L. PET studies of drug interaction with brain regional glucose metabolism. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:472A-473A. PMID: 1354054.
      View in: PubMed
    186. Gottschalk LA, Buchsbaum M, Gillin JC, Wu J, Reynolds CA, Herrera DB. The effect of anxiety and hostility in silent mentation on localized cerebral glucose metabolism. Compr Psychiatry. 1992 Jan-Feb; 33(1):52-9. PMID: 1555410.
      View in: PubMed
    187. Buchsbaum M, Kesslak JP, Lynch G, Chui H, Wu J, Sicotte N, Hazlett E, Teng E, Cotman CW. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies. Arch Gen Psychiatry. 1991 Sep; 48(9):840-7. PMID: 1929775.
      View in: PubMed
    188. Wu JC, Buchsbaum M, Hershey TG, Hazlett E, Sicotte N, Johnson JC. PET in generalized anxiety disorder. Biol Psychiatry. 1991 Jun 15; 29(12):1181-99. PMID: 1888800.
      View in: PubMed
    189. Gottschalk LA, Rebello T, Buchsbaum M, Tucker HG, Hodges EL. Abnormalities in hair trace elements as indicators of aberrant behavior. Compr Psychiatry. 1991 May-Jun; 32(3):229-37. PMID: 1884602.
      View in: PubMed
    190. Wu JC, Gillin JC, Buchsbaum M, Hershey T, Hazlett E, Sicotte N, Bunney WE. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Sleep. 1991 Apr; 14(2):155-62. PMID: 1866529.
      View in: PubMed
    191. Wu JC, Buchsbaum M, Bunney WE. Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia. Yakubutsu Seishin Kodo. 1991 Feb; 11(1):47-8. PMID: 1882590.
      View in: PubMed
    192. Gottschalk LA, Buchsbaum M, Gillin JC, Wu JC, Reynolds CA, Herrera DB. Anxiety levels in dreams: relation to localized cerebral glucose metabolic rate. Brain Res. 1991 Jan 04; 538(1):107-10. PMID: 2018922.
      View in: PubMed
    193. Hoffman RE, Buchsbaum M, Escobar MD, Makuch RW, Nuechterlein KH, Guich SM. EEG coherence of prefrontal areas in normal and schizophrenic males during perceptual activation. J Neuropsychiatry Clin Neurosci. 1991; 3(2):169-75. PMID: 1821231.
      View in: PubMed
    194. Gottschalk LA, Buchsbaum M, Gillin JC, Wu J, Reynolds CA, Herrera DB. Positron-emission tomographic studies of the relationship of cerebral glucose metabolism and the magnitude of anxiety and hostility experienced during dreaming and waking. J Neuropsychiatry Clin Neurosci. 1991; 3(2):131-42. PMID: 1821226.
      View in: PubMed
    195. Hagman JO, Buchsbaum M, Wu JC, Rao SJ, Reynolds CA, Blinder BJ. Comparison of regional brain metabolism in bulimia nervosa and affective disorder assessed with positron emission tomography. J Affect Disord. 1990 Jul; 19(3):153-62. PMID: 2145335.
      View in: PubMed
    196. Wu JC, Hagman J, Buchsbaum M, Blinder B, Derrfler M, Tai WY, Hazlett E, Sicotte N. Greater left cerebral hemispheric metabolism in bulimia assessed by positron emission tomography. Am J Psychiatry. 1990 Mar; 147(3):309-12. PMID: 2309947.
      View in: PubMed
    197. LaBerge D, Buchsbaum M. Positron emission tomographic measurements of pulvinar activity during an attention task. J Neurosci. 1990 Feb; 10(2):613-9. PMID: 2303863.
      View in: PubMed
    198. Buchsbaum M, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br J Psychiatry. 1990 Feb; 156:216-27. PMID: 2317626.
      View in: PubMed
    199. Morrow LA, Callender T, Lottenberg S, Buchsbaum M, Hodgson MJ, Robin N. PET and neurobehavioral evidence of tetrabromoethane encephalopathy. J Neuropsychiatry Clin Neurosci. 1990; 2(4):431-5. PMID: 2136397.
      View in: PubMed
    200. Buchsbaum M. Frontal lobes, basal ganglia, temporal lobes--three sites for schizophrenia? Schizophr Bull. 1990; 16(3):377-8. PMID: 2287928.
      View in: PubMed
    201. Buchsbaum M. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull. 1990; 16(3):379-89. PMID: 2287929.
      View in: PubMed
    202. Weiler MA, Buchsbaum M, Gillin JC, Tafalla R, Bunney WE. Explorations in the relationship of dream sleep to schizophrenia using positron emission tomography. Neuropsychobiology. 1990-1991; 23(3):109-18. PMID: 2098666.
      View in: PubMed
    203. Guich SM, Buchsbaum M, Burgwald L, Wu J, Haier R, Asarnow R, Nuechterlein K, Potkin S. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia. Schizophr Res. 1989 Nov-Dec; 2(6):439-48. PMID: 2487185.
      View in: PubMed
    204. DeLisi LE, Buchsbaum M, Holcomb HH, Langston KC, King AC, Kessler R, Pickar D, Carpenter WT, Morihisa JM, Margolin R. Increased temporal lobe glucose use in chronic schizophrenic patients. Biol Psychiatry. 1989 Apr 01; 25(7):835-51. PMID: 2785820.
      View in: PubMed
    205. Irving JB, Coursey RD, Buchsbaum M, Murphy DL. Platelet monoamine oxidase activity and life stress as predictors of psychopathology and coping in a community sample. Psychol Med. 1989 Feb; 19(1):79-90. PMID: 2727212.
      View in: PubMed
    206. Heh CW, Smith R, Wu J, Hazlett E, Russell A, Asarnow R, Tanguay P, Buchsbaum M. Positron emission tomography of the cerebellum in autism. Am J Psychiatry. 1989 Feb; 146(2):242-5. PMID: 2783541.
      View in: PubMed
    207. Buchsbaum M, Gillin JC, Wu J, Hazlett E, Sicotte N, Dupont RM, Bunney WE. Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci. 1989; 45(15):1349-56. PMID: 2796606.
      View in: PubMed
    208. Heh CW, Herrera J, DeMet E, Potkin S, Costa J, Sramek J, Hazlett E, Buchsbaum M. Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophrenia. Neuropsychopharmacology. 1988 May; 1(2):149-56. PMID: 3251495.
      View in: PubMed
    209. Haier RJ, Buchsbaum M, DeMet E, Wu J. Biological vulnerability to depression: replication of MAO and evoked potentials as risk factors. Neuropsychobiology. 1988; 20(2):62-6. PMID: 3253603.
      View in: PubMed
    210. Buchsbaum M, Lee S, Haier R, Wu JC, Green M, Tang SW. Effects of amoxapine and imipramine on evoked potentials in the Continuous Performance Test in patients with affective disorder. Neuropsychobiology. 1988; 20(1):15-22. PMID: 3068567.
      View in: PubMed
    211. Buchsbaum M, Wu J, Haier R, Hazlett E, Ball R, Katz M, Sokolski K, Lagunas-Solar M, Langer D. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. Life Sci. 1987 Jun 22; 40(25):2393-400. PMID: 2884547.
      View in: PubMed
    212. Post RM, DeLisi LE, Holcomb HH, Uhde TW, Cohen R, Buchsbaum M. Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography. Biol Psychiatry. 1987 May; 22(5):545-53. PMID: 3495297.
      View in: PubMed
    213. Buchsbaum M, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper-Langston K, Kessler R. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biol Psychiatry. 1987 Apr; 22(4):479-94. PMID: 2882788.
      View in: PubMed
    214. Buchsbaum M, Wu JC. Hypofrontality in schizophrenia as assessed by PET. Am J Psychiatry. 1987 Jan; 144(1):122-3. PMID: 2879481.
      View in: PubMed
    215. Buchsbaum M. Brain imaging in the search for biological markers in affective disorder. J Clin Psychiatry. 1986 Oct; 47 Suppl:7-12. PMID: 3489711.
      View in: PubMed
    216. Buchsbaum M, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, King AC, Hazlett E, Langston K, Post RM. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord. 1986 Mar-Apr; 10(2):137-52. PMID: 2941470.
      View in: PubMed
    217. Buchsbaum M, Awsare SV, Holcomb HH, DeLisi LE, Hazlett E, Carpenter WT, Pickar D, Morihisa JM. Topographic differences between normals and schizophrenics: the N120 evoked potential component. Neuropsychobiology. 1986; 15(1):1-6. PMID: 3724994.
      View in: PubMed
    218. Buchsbaum M, Hazlett E, Sicotte N, Stein M, Wu J, Zetin M. Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder. Biol Psychiatry. 1985 Aug; 20(8):832-42. PMID: 2862924.
      View in: PubMed
    219. DeLisi LE, Holcomb HH, Cohen RM, Pickar D, Carpenter W, Morihisa JM, King AC, Kessler R, Buchsbaum M. Positron emission tomography in schizophrenic patients with and without neuroleptic medication. J Cereb Blood Flow Metab. 1985 Jun; 5(2):201-6. PMID: 2859295.
      View in: PubMed
    220. Buchsbaum M, Haier RJ, Sostek AJ, Weingartner H, Zahn TP, Siever LJ, Murphy DL. Attention dysfunction and psychopathology in college men. Arch Gen Psychiatry. 1985 Apr; 42(4):354-60. PMID: 3977552.
      View in: PubMed
    221. DeLisi LE, Buchsbaum M, Holcomb HH, Dowling-Zimmerman S, Pickar D, Boronow J, Morihisa JM, van Kammen DP, Carpenter W, Kessler R. Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients. Am J Psychiatry. 1985 Jan; 142(1):78-81. PMID: 3871312.
      View in: PubMed
    222. Roy-Byrne P, Uhde TW, Post RM, King AC, Buchsbaum M. Normal pain sensitivity in patients with panic disorder. Psychiatry Res. 1985 Jan; 14(1):77-84. PMID: 3857650.
      View in: PubMed
    223. Buchsbaum M, DeLisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry. 1984 Dec; 41(12):1159-66. PMID: 6334502.
      View in: PubMed
    224. Siever LJ, Coursey RD, Alterman IS, Buchsbaum M, Murphy DL. Impaired smooth pursuit eye movement: vulnerability marker for schizotypal personality disorder in a normal volunteer population. Am J Psychiatry. 1984 Dec; 141(12):1560-6. PMID: 6507660.
      View in: PubMed
    225. Buchsbaum M, Mirsky AF, DeLisi LE, Morihisa J, Karson CN, Mendelson WB, King AC, Johnson J, Kessler R. The Genain Quadruplets: electrophysiological, positron emission, and X-ray tomographic studies. Psychiatry Res. 1984 Sep; 13(1):95-108. PMID: 6334864.
      View in: PubMed
    226. Mirsky AF, DeLisi LE, Buchsbaum M, Quinn OW, Schwerdt P, Siever LJ, Mann L, Weingartner H, Zec R, Sostek A. The Genain Quadruplets: psychological studies. Psychiatry Res. 1984 Sep; 13(1):77-93. PMID: 6151205.
      View in: PubMed
    227. Clark CM, Kessler R, Buchsbaum M, Margolin RA, Holcomb HH. Correlational methods for determining regional coupling of cerebral glucose metabolism: a pilot study. Biol Psychiatry. 1984 May; 19(5):663-78. PMID: 6610442.
      View in: PubMed
    228. Buchsbaum M, Kessler R, King A, Johnson J, Cappelletti J. Simultaneous cerebral glucography with positron emission tomography and topographic electroencephalography. Prog Brain Res. 1984; 62:263-9. PMID: 6335920.
      View in: PubMed
    229. Buchsbaum M, Cappelletti J, Ball R, Hazlett E, King AC, Johnson J, Wu J, DeLisi LE. Positron emission tomographic image measurement in schizophrenia and affective disorders. Ann Neurol. 1984; 15 Suppl:S157-65. PMID: 6611116.
      View in: PubMed
    230. Buchsbaum M, Holcomb HH, Johnson J, King AC, Kessler R. Cerebral metabolic consequences of electrical cutaneous stimulation in normal individuals. Hum Neurobiol. 1983; 2(1):35-8. PMID: 6603452.
      View in: PubMed
    231. Uhde TW, Siever LJ, Post RM, Jimerson DC, Boulenger JP, Buchsbaum M. The relationship of plasma free MHPG to anxiety and psycho-physical pain in normal volunteers. Psychopharmacol Bull. 1982 Oct; 18(4):129-32. PMID: 7156274.
      View in: PubMed
    232. Siever LJ, Haier RJ, Coursey RD, Sostek AJ, Murphy DL, Holzman PS, Buchsbaum M. Smooth pursuit eye tracking impairment: relation to other 'markers' of schizophrenia and psychologic correlates. Arch Gen Psychiatry. 1982 Sep; 39(9):1001-5. PMID: 7115010.
      View in: PubMed
    233. Buchsbaum M, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, King AC, Johnson JL, Manning RG, Flynn RW, Mann LS, Bunney WE, Sokoloff L. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry. 1982 Mar; 39(3):251-9. PMID: 6978119.
      View in: PubMed
    234. Buchsbaum M, Mendelson WB, Duncan WC, Coppola R, Kelsoe J, Gillin JC. Topographic cortical mapping of EEG sleep stages during daytime naps in normal subjects. Sleep. 1982; 5(3):248-55. PMID: 7134731.
      View in: PubMed
    235. Davis GC, Buchsbaum M, Naber D, Pickar D, Post R, van Kammen D, Bunney WE. Altered pain perception and cerebrospinal endorphins in psychiatric illness. Ann N Y Acad Sci. 1982; 398:366-73. PMID: 6961863.
      View in: PubMed
    236. Buchsbaum M, Reus VI, Davis GC, Holcomb HH, Cappelletti J, Silberman E. Role of opioid peptides in disorders of attention in psychopathology. Ann N Y Acad Sci. 1982; 398:352-65. PMID: 6297359.
      View in: PubMed
    237. Rapoport J, Elkins R, Langer DH, Sceery W, Buchsbaum M, Gillin JC, Murphy DL, Zahn TP, Lake R, Ludlow C, Mendelson W. Childhood obsessive-compulsive disorder. Am J Psychiatry. 1981 Dec; 138(12):1545-54. PMID: 7304788.
      View in: PubMed
    238. Rapoport JL, Jensvold M, Elkins R, Buchsbaum M, Weingartner H, Ludlow C, Zahn TP, Berg CJ, Neims AH. Behavioral and cognitive effects of caffeine in boys and adult males. J Nerv Ment Dis. 1981 Nov; 169(11):726-32. PMID: 7299385.
      View in: PubMed
    239. Schulz SC, van Kammen DP, Buchsbaum M, Roth RH, Alexander P, Bunney WE. Gamma-hydroxybutyrate treatment of schizophrenia: a pilot study. Pharmacopsychiatria. 1981 Jul; 14(4):129-34. PMID: 7280012.
      View in: PubMed
    240. Buchsbaum M, Gerner R, Post RM. The effects of sleep deprivation on average evoked responses in depressed patients and in normals. Biol Psychiatry. 1981 Apr; 16(4):351-63. PMID: 7225492.
      View in: PubMed
    241. Elkins RN, Rapoport JL, Zahn TP, Buchsbaum M, Weingartner H, Kopin IJ, Langer D, Johnson C. Acute effects of caffeine in normal prepubertal boys. Am J Psychiatry. 1981 Feb; 138(2):178-83. PMID: 7457638.
      View in: PubMed
    242. Davis GC, Buchsbaum M, Bunney WE. Opiates, opioid peptides and psychiatry. Ann N Y Acad Sci. 1981; 362:67-75. PMID: 7020533.
      View in: PubMed
    243. Buchsbaum M, Muscettola G, Goodwin FK. Urinary MHPG, stress response, personality factors and somatosensory evoked potentials in normal subjects and patients with major affective disorders. Neuropsychobiology. 1981; 7(4):212-24. PMID: 7196513.
      View in: PubMed
    244. Uhde TW, Post RM, Siever LJ, Buchsbaum M. Clonidine and psychophysical pain. Lancet. 1980 Dec 20-27; 2(8208-8209):1375. PMID: 6109195.
      View in: PubMed
    245. Rapoport JL, Buchsbaum M, Weingartner H, Zahn TP, Ludlow C, Mikkelsen EJ. Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry. 1980 Aug; 37(8):933-43. PMID: 7406657.
      View in: PubMed
    246. Breakefield XO, Giller EL, Nurnberger JI, Castiglione CM, Buchsbaum M, Gershon ES. Monoamine oxidase type A in fibroblasts from patients with bipolar depressive illness. Psychiatry Res. 1980 Jul; 2(3):307-14. PMID: 6932070.
      View in: PubMed
    247. Haier RJ, Buchsbaum M, Murphy DL, Gottesman II, Coursey RD. Psychiatric vulnerability, monoamine oxidase, and the average evoked potential. Arch Gen Psychiatry. 1980 Mar; 37(3):340-5. PMID: 7362421.
      View in: PubMed
    248. Weingartner H, Rapoport JL, Buchsbaum M, Bunney WE, Ebert MH, Mikkelsen EJ, Caine ED. Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. J Abnorm Psychol. 1980 Feb; 89(1):25-37. PMID: 7365116.
      View in: PubMed
    249. Davis GC, Buchsbaum M, Bunney WE. Alterations of evoked potentials link research in attention dysfunction to peptide response symptoms of schizophrenia. Adv Biochem Psychopharmacol. 1980; 22:473-87. PMID: 7395603.
      View in: PubMed
    250. Buchsbaum M, Coursey RD, Murphy DL. Schizophrenia and platelet monoamine oxidase: research strategies. Schizophr Bull. 1980; 6(2):375-84. PMID: 6103578.
      View in: PubMed
    251. Kleinman JE, Potkin S, Rogol A, Buchsbaum M, Murphy DL, Gillin JC, Nasrallah HA, Wyatt RJ. A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. Science. 1979 Oct 26; 206(4417):479-81. PMID: 504993.
      View in: PubMed
    252. Buchsbaum M, Rieder RO. Biologic heterogeneity and psychiatrict research. Platelet MAO activity as a case study. Arch Gen Psychiatry. 1979 Oct; 36(11):1163-9. PMID: 485775.
      View in: PubMed
    253. Davis GC, Buchsbaum M, Bunney WE. Analgesia to painful stimuli in affective illness. Am J Psychiatry. 1979 Sep; 136(9):1148-51. PMID: 474801.
      View in: PubMed
    254. Davis GC, Buchsbaum M, van Kammen DP, Bunney WE. Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone. Psychiatry Res. 1979 Jul; 1(1):61-9. PMID: 298339.
      View in: PubMed
    255. Haier RJ, Rieder RO, Khouri PJ, Buchsbaum M. Extreme MMPI scores and the Research Diagnostic Criteria. Screening college men for psychopathology. Arch Gen Psychiatry. 1979 May; 36(5):528-34. PMID: 435013.
      View in: PubMed
    256. Lipper S, Murphy DL, Slater S, Buchsbaum M. Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation. Psychopharmacology (Berl). 1979 Apr 11; 62(2):123-8. PMID: 111274.
      View in: PubMed
    257. Davis GC, Buchsbaum M, Bunney WE. Research in endorphins and schizophrenia. Schizophr Bull. 1979; 5(2):244-50. PMID: 37596.
      View in: PubMed
    258. Davis GC, Buchsbaum M, Bunney WE. Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials. Life Sci. 1978 Oct 09; 23(14):1449-59. PMID: 568705.
      View in: PubMed
    259. Mendelson WB, Buchsbaum M, Murphy DL, Wyatt RJ, Gillin JC. Platelet monoamine oxidase activity and human sleep. Commun Psychopharmacol. 1978; 2(6):539-44. PMID: 218771.
      View in: PubMed
    260. Buchsbaum M, Murphy DL, Coursey RD, Lake CR, Zeigler MG. Platelet monoamine oxidase, plasma dopamine-beta-hydroxylase and attention in a "biochemical high risk" sample. J Psychiatr Res. 1978; 14(1-4):215-24. PMID: 722628.
      View in: PubMed
    261. Buchsbaum M, Davis GC, Bunney WE. Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature. 1977 Dec 15; 270(5638):620-22. PMID: 339110.
      View in: PubMed
    262. Sitaram N, Buchsbaum M, Gillin JC. Physostigmine analgesia and somatosensory evoked responses in man. Eur J Pharmacol. 1977 Apr 07; 42(3):285-90. PMID: 323025.
      View in: PubMed
    263. Post RM, Stoddard FJ, Gillin JC, Buchsbaum M, Runkle DC, Black KE, Bunney WE. Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient. Arch Gen Psychiatry. 1977 Apr; 34(4):470-7. PMID: 192169.
      View in: PubMed
    264. Buchsbaum M, Post RM, Bunney WE. Average evoked responses in a rapidly cycling manic-depressive patient. Biol Psychiatry. 1977 Feb; 12(1):83-99. PMID: 836924.
      View in: PubMed
    265. Buchsbaum M. The middle evoked response components and schizophrenia. Schizophr Bull. 1977; 3(1):93-104. PMID: 17155.
      View in: PubMed
    266. Schooler C, Buchsbaum M, Carpenter WT. Evoked response and kinesthetic measures of augmenting/reducing in schizophrenics: replications and extensions. J Nerv Ment Dis. 1976 Oct; 163(4):221-32. PMID: 972324.
      View in: PubMed
    267. Landau SG, Buchsbaum M, Carpenter W, Strauss J, Sacks M. Schizophrenia and stimulus intensity control. Arch Gen Psychiatry. 1975 Oct; 32(10):1239-45. PMID: 1180658.
      View in: PubMed
    268. Gillin JC, Buchsbaum M, Jacobs LS, Fram DH, Williams RB, Vaughan TB, Mellon E, Snyder F, Wyatt RJ. Partial REM sleep deprivation, schizophrenia and field articulation. Arch Gen Psychiatry. 1974 May; 30(5):653-62. PMID: 4363107.
      View in: PubMed